☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
80-0765058
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.00001 per share
|
MNTV
|
The Nasdaq Stock Market LLC
(The Nasdaq Global Select Market)
|
Large accelerated filer ☒
|
Accelerated filer ☐
|
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
|
Emerging growth company ☐
|
Page
|
||
2 | ||
PART III
|
||
Item 10.
|
3
|
|
3
|
||
6 |
||
6 |
||
7 |
||
7 |
||
8 |
||
8 |
||
9 |
||
9 |
||
9 |
||
10 |
||
11 |
||
11 |
||
11 |
||
Item 11.
|
12 | |
12 |
||
34 |
||
35 |
||
36 |
||
38 |
||
38 |
||
40 |
||
41 |
||
42 |
||
42 |
||
42 |
||
44 |
||
Item 12.
|
45 | |
45 |
||
46 |
||
Item 13.
|
49 | |
49 |
||
49 |
||
49 |
||
49 |
||
49 |
||
Item 14.
|
50
|
|
50 |
||
50 |
||
50 |
||
PART IV
|
||
Item 15.
|
51 | |
Item 10. |
Directors, Executive Officers and Corporate Governance
|
Name
|
Class
|
Age
|
Position
|
Director
Since
|
Current
Term
Expires
|
||||||||||
Alexander J. “Zander” Lurie
|
I
|
49
|
Chief Executive Officer & Director
|
2009
|
2023
|
||||||||||
Lauren Antonoff(2)
|
II
|
52
|
Director
|
2022
|
2023
|
||||||||||
Dana L. Evan(1)
|
I |
|
63
|
Director
|
2012
|
2023
|
|||||||||
Ryan Finley(3)
|
II
|
46
|
Director
|
1999
|
2023
|
||||||||||
Sagar Gupta(4)
|
I
|
35
|
Director
|
2022
|
2023
|
||||||||||
Benjamin C. Spero(1)(2)
|
II
|
47
|
Director
|
2009
|
2023
|
||||||||||
Susan L. Decker(1)(4)
|
III
|
60
|
Director
|
2017
|
2024
|
||||||||||
David A. Ebersman(3)(4)
|
III
|
53
|
Chair of the Board
|
2015
|
2024
|
||||||||||
Erika H. James(3)
|
III
|
53
|
Director
|
2018
|
2024
|
||||||||||
Sheryl K. Sandberg(2)
|
III
|
53
|
Director
|
2015
|
2024
|
(1) |
Member of our audit committee.
|
(2) |
Member of our compensation committee.
|
(3) |
Member of our nominating and corporate governance committee.
|
(4) |
Member of our strategic committee.
|
Name of Director
|
Audit
Committee
|
Compensation
Committee
|
Nominating and
Corporate
Governance
Committee
|
Strategic
Committee
|
||||
Lauren Antonoff(1)
|
Member
|
|||||||
Susan L. Decker
|
Member
|
Chair
|
||||||
Ryan Finley(2)
|
Member
|
|||||||
Sagar Gupta
|
Member
|
|||||||
David A. Ebersman
|
Member
|
Member
|
||||||
Dana L. Evan
|
Chair
|
|||||||
Erika H. James
|
Chair
|
|||||||
Sheryl K. Sandberg
|
Member
|
|||||||
Benjamin C. Spero
|
Member
|
Chair
|
||||||
Total Number of Meetings
|
4
|
5
|
3
|
15
|
(1) |
Ms. Antonoff was appointed as a member of the compensation committee effective November 9, 2022, replacing Mr. Finley, who resigned therefrom on November 9, 2022.
|
(2) |
Mr. Finley served as a member of the compensation committee until November 9, 2022, and was appointed as a member of the nominating and corporate governance committee
effective November 9, 2022, replacing Ms. Decker, who resigned therefrom on November 9, 2022.
|
• |
selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
|
• |
helping to ensure the independence and overseeing performance of the independent registered public accounting firm;
|
• |
reviewing and discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent
registered public accounting firm, our interim and year-end operating results;
|
• |
reviewing our financial statements and our critical accounting policies and estimates;
|
• |
reviewing the adequacy and effectiveness of our internal controls;
|
• |
developing and overseeing procedures for employees to submit concerns anonymously about questionable accounting, internal accounting controls or audit matters;
|
• |
overseeing our policies on risk assessment and risk management;
|
• |
overseeing compliance with our code of business conduct and ethics;
|
• |
reviewing related party transactions; and
|
• |
pre-approving all audit and all permissible non-audit services, other than de minimis non-audit services, to be performed by the independent registered public accounting
firm.
|
• |
reviewing, approving and determining, or making recommendations to our board of directors regarding, the compensation of our executive officers;
|
• |
administering our equity compensation plans;
|
• |
reviewing and approving and making recommendations to our board of directors regarding incentive compensation and equity compensation plans;
|
• |
establishing and reviewing general policies relating to compensation and benefits of our employees; and
|
• |
making recommendations regarding non-employee director compensation to our full board of directors.
|
• |
identifying, evaluating and selecting, or making recommendations to our board of directors regarding, nominees for election to our board of directors and its committees;
|
• |
evaluating the performance of our board of directors and of individual directors;
|
• |
considering and making recommendations to our board of directors regarding the composition of our board of directors and its committees;
|
• |
reviewing developments in corporate governance practices;
|
• |
evaluating the adequacy of our corporate governance practices and reporting;
|
• |
approving our committee charters;
|
• |
overseeing compliance with our code of business conduct and ethics;
|
• |
overseeing the Company’s strategy, policies and practices relating to environmental, social and governance matters;
|
• |
contributing to succession planning;
|
• |
reviewing actual and potential conflicts of interest of our directors and officers other than related party transactions reviewed by our audit committee; and
|
• |
developing and making recommendations to our board of directors regarding corporate governance guidelines and matters.
|
Name
|
Age
|
Position
|
||
Zander Lurie
|
49
|
Chief Executive Officer & Director
|
||
Lora D. Blum
|
49
|
Chief Legal Officer and Secretary
|
||
Rebecca Cantieri
|
48
|
Chief People Officer
|
||
Priyanka Carr
|
37
|
Chief Operating Officer
|
||
Clarence “Ken” Ewell
|
57
|
Chief Customer Officer
|
||
Richard E. “Rich” Sullivan, Jr.
|
50
|
Chief Financial Officer
|
• |
On October 12, 2022, Legion Partners Asset Management, LLC and certain of its affiliates (the “Legion Group”), which has determined that it may be deemed a director by
deputization by virtue of its representation on our board of directors, filed a Form 3 to report Legion Group’s aggregate holdings as of March 1, 2022.
|
• |
The Legion Group also filed a Form 4 on October 12, 2022, to report the Legion Group’s purchase of an aggregate 772,500
shares of our common stock on August 22, 2022.
|
Item 11. |
Executive Compensation
|
• |
Alexander J. “Zander” Lurie, our Chief Executive Officer, interim Chief Financial Officer (from September 30, 2022 through December 12, 2022) and Director (our “CEO”);
|
• |
Richard E. “Rich” Sullivan, Jr., our Chief Financial Officer;
|
• |
Lora D. Blum, our Chief Legal Officer and Secretary;
|
• |
Clarence “Ken” Ewell, our Chief Customer Officer;
|
• |
Priyanka Carr, our Chief Operating Officer;
|
• |
Justin Coulombe, our former Chief Financial Officer (until September 30, 2022); and
|
• |
John S. Schoenstein, our former Chief Revenue Officer (until October 3, 2022).
|
• |
Total revenue was $480.9 million, an increase of 8% year-over-year. On a constant currency basis, revenue increased 9% year-over-year.
|
•
|
Sales-assisted revenue was $181.3 million, an increase of 27% year-over year.
|
• |
Self-serve revenue was $299.6 million, approximately flat year-over-year.
|
• |
GAAP operating margin was negative 16.9% and non-GAAP operating margin was 7.9%.
|
• |
GAAP net loss was $89.9 million and GAAP diluted net loss per share was $0.61. Non-GAAP net income was $27.1 million and non-GAAP diluted net income per share was $0.18.
|
• |
Net cash provided by operating activities was $8.8 million and free cash flow was $0.1 million. Cash and cash equivalents totaled $202.8 million and total debt was $184.8
million for net cash of $18.0 million as of December 31, 2022.
|
• |
The Company repurchased approximately 6.6 million shares of common stock for approximately $83.5 million. As of December 31, 2022, the Company’s remaining share repurchase
authorization was approximately $116.5 million.
|
(1) |
To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures. For a full
reconciliation of the GAAP to non-GAAP measures, please see Exhibit 99.1 to our Current Report on Form 8-K, filed with the SEC February 16, 2023.
|
• |
Maintain Independent Compensation Committee. The compensation committee is comprised solely of independent directors who determine our compensation policies and practices and who have established effective means for communicating with our stockholders regarding their
executive compensation views and concerns, as described in this 10-K/A.
|
• |
Annual Executive Compensation Review.
The compensation committee reviews and approves our compensation strategy annually, including a review of our compensation peer group used for comparative purposes and a review of our compensation-related risk profile to ensure that our
compensation programs do not encourage excessive or inappropriate risk-taking and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on the Company.
|
• |
Maintain Independent Compensation Advisor. The compensation committee has engaged its own compensation consultant to assist with its 2022 compensation review. This consultant performed no other consulting or other services for us in 2022.
|
• |
Compensation At-Risk. Our executive
compensation program is designed so that a significant portion of our Named Executive Officers’ compensation is “at risk” based on corporate performance, as well as equity-based, to align the interests of our Named Executive Officers and
stockholders.
|
• |
Multi-Year Vesting Requirements. The
annual equity awards granted to our Named Executive Officers vest over multi-year periods, consistent with current market practice and our retention objectives.
|
• |
Stock Ownership Guidelines. We maintain
a stock ownership policy for our Chief Executive Officer and the non-employee members of our board of directors.
|
• |
Compensation Clawback Policy. In the
event of a material restatement of our financial results, a violation of a non-compete covenant, or an ethical or criminal violation, our officers who were subject to Section 16 of the Securities Exchange Act of 1934 and certain executive
vice presidents may be required to forfeit and repay any incentive-based compensation paid to them beginning with the 2021 performance period.
|
• |
“Double-Trigger” Change-in-Control Arrangements. All change-in-control payments and benefits are based on a “double-trigger” arrangement (that is, they require both a change-in-control of the Company plus a qualifying termination of employment before payments and benefits are
paid).
|
• |
Health and Welfare Benefits. Our Named
Executive Officers participate in broad-based Company-sponsored health and welfare benefit programs on the same basis as our other full-time, salaried employees.
|
• |
Succession Planning. We review the
risks associated with our key executive officer positions to ensure adequate succession plans are in place.
|
• |
No Executive Retirement Plans. We do
not currently offer, nor do we have plans to offer, defined benefit pension plans or any non-qualified deferred compensation plans or arrangements to our Named Executive Officers other than the plans and arrangements that are available to
all employees. Our Named Executive Officers are eligible to participate in our Section 401(k) retirement plan on the same basis as our other employees.
|
• |
No Excessive Perquisites. We provide
minimal perquisites and other personal benefits to our Named Executive Officers.
|
• |
No Tax Payments on Perquisites. We do
not provide any tax reimbursement payments (including “gross-ups”) on any perquisites or other personal benefits, other than on standard relocation benefits.
|
• |
No Tax Payments on Change-in-Control Arrangements. We do not provide any excise tax reimbursement payments (including “gross-ups”) on payments or benefits contingent upon a change in control of the Company.
|
• |
No Hedging or Pledging of our Equity Securities. We prohibit our employees, including our Named Executive Officers, and the non-employee members of our board of directors from hedging or pledging our equity securities.
|
• |
Base Salaries. Approved a base salary
increase of 7.2%, to $520,000, for our CEO and annual base salary increases ranging from 4.2% to 12.0% for our other Named Executive Officers who did not first become Named Executive Officers in 2022.
|
• |
Annual Cash Bonuses. Approved changes
to the annual bonus plan design for fiscal 2022 to shift the weighting of 2022 performance metrics to 50% revenue and 50% Non-GAAP operating income (prior to 2022, weighting was 70% revenue and 30% Non-GAAP operating income) to emphasize
profitability. We also gave our CEO discretion to adjust Named Executive Officer bonus payments for 2022 performance using an individual performance multiplier that ranges from 0% - 130% of the resulting corporate score. Given the
results of our corporate goals yielded a multiplier below 75% (54.5% for 2022) the individual performance multiplier was capped with a range from 0% - 100%. Discretion was reviewed and approved by the compensation committee, where
applied.
|
• |
Long-Term Incentive Compensation. Our
goal is to deliver market competitive long-term incentive compensation opportunities that help motivate and retain our executives. As a part of our ongoing diligence, we monitor the retentiveness of the outstanding equity holdings of our
Named Executive Officer group and maintain the flexibility to address issues in the unvested holdings with respect to our Named Executive Officers. We exercised such discretion in 2022 given the volatility in the market.
|
• |
Management Retention Equity Grants. Additionally, we granted additional long-term incentive opportunities in the form of stock options to address retention concerns due to the volatility in the stock price and its effect on the retentive
power of our Named Executive Officer’s equity holdings. Of the management team, three of our Named Executive Officer received these retention awards; our CEO did not receive a retention award.
|
• |
Appointment of Chief Operating Officer.
In connection with Ms. Carr’s promotion to Chief Operating Officer of our Company, we entered into an employment offer letter dated February 18, 2022 with Ms. Carr. The terms of our compensation arrangements with Ms. Carr were as follows:
|
o |
An annual base salary of $380,000.
|
o |
A target annual cash bonus opportunity under the Executive Bonus Plan equal to 70% of her annual base salary, which will be pro-rated for the 2022 fiscal year.
|
o |
Ms. Carr’s Change in Control and Severance Agreement was amended to provide payments and benefits that are aligned with a Section 16 position in our structure. The
payments would be made if her employment is either terminated without cause or she resigns for good reason, including in connection with a change in control of the Company. For a description of these post-employment compensation
arrangements, see “Potential Payments upon Termination or Change in Control” below.
|
o |
Ms. Carr entered into our standard form of Indemnification Agreement.
|
o |
The grant date fair value of the equity awards granted to Ms. Carr are set forth in the “2022
Summary Compensation Table” and the “2022 Grants of Plan-Based Awards Table” below.
|
• |
Expansion of Role of Chief Customer Officer. In connection with the expansion of Mr. Ewell’s role as Chief Customer Officer to assume the responsibilities of our sales-assisted business, we entered into an employment offer letter dated August 1, 2022 with Mr. Ewell. The terms
of our compensation arrangements with Mr. Ewell were as follows:
|
o |
An annual base salary of $415,000.
|
o |
A target annual cash bonus opportunity under the Executive Bonus Plan equal to 70% of his annual base salary, which will be pro-rated for the 2022 fiscal year.
|
o |
An RSU grant equal to $630,000 in value for shares of our common stock, which will vest over a three-year period, with one-twelfth of the RSUs vesting in mid-November 2022
and the remaining shares vesting quarterly thereafter.
|
o |
Mr. Ewell’s Change in Control and Severance Agreement was amended to provide payments and benefits that are aligned with a Section 16 position in our structure. The
payments would be made if his employment is either terminated without cause or he resigns for good reason, including in connection with a change in control of the Company. For a description of these post-employment compensation
arrangements, see “Potential Payments upon Termination or Change in Control” below.
|
o |
The grant date fair value of the equity awards granted to Mr. Ewell are set forth in “2022 Summary
Compensation Table” and the “2022 Grants of Plan-Based Awards Table” below.
|
• |
Appointment of Chief Financial Officer.
In connection with Mr. Sullivan’s appointment as our Chief Financial Officer, we entered into an employment offer letter dated November 18, 2022 with Mr. Sullivan. The terms of our initial compensation arrangements with Mr. Sullivan were
as follows:
|
o |
An initial annual base salary of $430,000.
|
o |
A target annual cash bonus opportunity under the Executive Bonus Plan equal to 70% of his annual base salary, beginning fiscal 2023. In addition, Mr. Sullivan received a
signing bonus totaling $150,000, half of which was paid upon start and the other half was paid in alignment with the timing of the 2022 corporate bonus payments.
|
o |
An RSU grant equal to $2,500,000 in value for shares of our common stock, which will vest over a four-year period, with one quarter of the RSUs vesting on the first
anniversary of the vesting commencement date (with the first vesting date anticipated to be in November 2023) and the remaining shares vesting ratably over the following three years on successive quarterly vesting dates.
|
o |
An RSU grant equal to $2,500,000 in value for shares of our common stock, which will vest over a one-year period, with one quarter of the RSUs vesting on May 15, 2023, and
the remaining shares vesting ratably over the following three quarters.
|
o |
Mr. Sullivan also entered into a Change in Control and Severance Agreement that provides for certain payments and benefits if his employment is either terminated without
cause or he resigns for good reason, including in connection with a change in control of the Company. For a description of these post-employment compensation arrangements, see “Potential Payments upon Termination or Change in Control” below.
|
o |
Mr. Sullivan entered into our standard form of Indemnification Agreement.
|
o |
The grant date fair value of the equity awards granted to Mr. Sullivan are set forth in the “2022
Summary Compensation Table” and the “2022 Grants of Plan-Based Awards Table” below.
|
• |
First, we provide the opportunity to participate in our Executive Bonus Plan, which provides cash payments if they produce short-term results aligned with long-term
stockholder value that meet or exceed certain business objectives set forth in our annual operating plan.
|
• |
In addition, we grant RSAs and RSUs, which in the aggregate comprise a majority of their target total direct compensation opportunities. We initially shifted the mix of
vehicles from 50% stock options and 50% RSAs to 100% RSAs and/or RSUs to better align with the trends within our compensation peer group and help improve our annual dilution profile, but in 2022, we granted additional long-term incentive
opportunities to certain Named Executive Officers in the form of stock options to address retention concerns due to the volatility in the stock price. The value of these equity awards depends entirely on the value of our common stock,
thereby incentivizing our Named Executive Officers to build sustainable long-term value for the benefit of our stockholders.
|
• |
provide market competitive compensation opportunities and benefit levels that will attract, motivate, reward and retain a highly talented team of executives within the
context of responsible cost management that is internally consistent and fair;
|
• |
establish a direct link between our financial and operational results and strategic objectives and the compensation of our executives; and
|
• |
align the interests and objectives of our executives with those of our stockholders by linking their long-term incentive compensation opportunities to stockholder value
creation and their cash incentives to our annual performance.
|
• |
the review, analysis and updating of our compensation peer group;
|
• |
the review and analysis of the base salary levels, annual cash bonus opportunities and long-term incentive compensation opportunities of our Named Executive Officers
against competitive market data based on the companies in our compensation peer group and selected compensation surveys;
|
• |
an assessment of executive compensation trends within our industry, and updating on corporate governance and regulatory issues and developments;
|
• |
an analysis of the Company’s equity utilization;
|
• |
a compensation risk assessment;
|
• |
consultation with the compensation committee chair and other members between compensation committee meetings; and
|
• |
support on other ad hoc matters throughout the year.
|
• |
publicly traded, U.S. Headquartered companies, with a preference on companies located in the San Francisco Bay Area or the U.S. west coast;
|
• |
similar industry – companies with a primary focus on cloud-based software, but including broader software industries where otherwise warranted;
|
• |
similar revenues – within a range of ~0.5x to ~2.0x of our trailing four fiscal quarters’ revenue of approximately $390 million (approximately $195 million to
approximately $974 million); and
|
• |
similar market capitalization – within a range of ~0.25x to ~4.0x of our then-market capitalization of approximately $3.1 billion (approximately $770 million to
approximately $12.3 billion).
|
Alteryx
|
Dropbox
|
Sumo Logic*
|
Anaplan*
|
LivePerson
|
Talend S.A.
|
Appfolio
|
Medallia
|
Yext
|
Blackline
|
New Relic
|
Zendesk
|
Box
|
Pager Duty*
|
Zuora
|
Cloudera
|
Smartsheet
|
|
Coupa Software
|
SPS Commerce
|
• |
our executive compensation program objectives;
|
• |
our performance against the financial, operational and strategic objectives established by the compensation committee and our board of directors;
|
• |
each individual Named Executive Officer’s knowledge, skills, experience, qualifications and tenure relative to other similarly situated executives at the companies in our
compensation peer group and/or selected broad-based compensation surveys;
|
• |
the scope of each Named Executive Officer’s role and responsibilities compared to other similarly situated executives at the companies in our compensation peer group
and/or selected broad-based compensation surveys;
|
• |
the prior performance of each individual Named Executive Officer, based on a subjective assessment of his or her contributions to our overall performance, ability to lead
his or her business unit or function and work as part of a team, all of which reflect our core values;
|
• |
the potential of each individual Named Executive Officer to contribute to our long-term financial, operational and strategic objectives;
|
• |
our CEO’s compensation relative to that of our Named Executive Officers, and compensation parity among our Named Executive Officers;
|
• |
our financial performance relative to our peers;
|
• |
the compensation practices of our compensation peer group and the companies in selected broad-based compensation surveys and the positioning of each Named Executive
Officer’s compensation in a ranking of peer company compensation levels based on an analysis of competitive market data; and
|
• |
the recommendations of our CEO with respect to the compensation of our Named Executive Officers (except with respect to his own compensation).
|
Element
|
Type of
Element
|
Compensation
Element
|
Objective
|
|||
Base Salary
|
Fixed
|
Cash
|
Designed to attract and retain executives by providing fixed compensation amounts that are competitive in the market and reward performance
|
|||
Annual Cash Bonuses
|
Variable
|
Cash
|
Designed to motivate our executives to achieve annual business objectives and provide financial incentives when we meet or exceed these annual objectives
|
|||
Long Term Incentive Compensation
|
Variable
|
Equity awards in the form of RSUs and RSAs for Named Executive Officers, other than the CEO
|
Designed to align the interests of our executives and our stockholders by motivating them to create sustainable long-term stockholder value
|
Named Executive Officer
|
2021
Base Salary($)
|
2022
Base Salary ($)(1)
|
Percentage
Adjustment (%)
|
|||||||||
Zander Lurie
|
485,000
|
520,000
|
7.2
|
%
|
||||||||
Justin Coulombe(2)
|
375,000
|
420,000
|
12.0
|
%
|
||||||||
Lora Blum
|
360,000
|
375,000
|
4.2
|
%
|
||||||||
John Schoenstein(3)
|
425,000
|
425,000
|
—
|
(1) |
These base salaries were effective February 1, 2022.
|
(2) |
Mr. Coulombe resigned from his position as Chief Financial Officer on September 30, 2022.
|
(3) |
Mr. Schoenstein resigned from his position as Chief Revenue Officer on October 3, 2022.
|
Named Executive Officer(1)
|
2022 Target Annual Cash
Bonus Opportunity
(as a percentage of base
salary)
|
2022 Target Annual Cash
Bonus Opportunity
($)(2)
|
||||||
Zander Lurie
|
100
|
%
|
517,027
|
|||||
Priyanka Carr(3)
|
70
|
%
|
260,989
|
|||||
Rich Sullivan(4)
|
70
|
%
|
N/A
|
|||||
Lora D. Blum
|
55
|
%
|
205,549
|
|||||
Ken Ewell(3)
|
70
|
%
|
228,130
|
(1) |
Mr. Coulombe and Mr. Schoenstein resigned prior to the end of our fiscal year and were not eligible for 2022 bonus payments.
|
(2) |
Amounts are based on actual earnings in 2022, not annual base salary rates, which were effective in February 2022.
|
(3) |
Pursuant to the terms of their respective offer letters, 2022 bonus targets were pro-rated in conjunction with the individual’s start date. Amounts shown above reflect
this proration.
|
(4) |
Mr. Sullivan joined the Company in December 2022 and was not eligible to receive a 2022 bonus payment.
|
• |
“revenue” meant our GAAP revenue, as reflected in our audited financial statements for 2022; and
|
• |
“non-GAAP operating income” was calculated as GAAP loss from operations excluding (i) stock-based compensation, net, (ii) acquisition-related transaction costs, (iii)
amortization of acquisition intangible assets, and (iv) restructuring costs.
|
Target Performance Level
(in millions)($)
|
||||||||||||
Corporate Performance Measure
|
Threshold
|
Target
|
Outperformance
|
|||||||||
Revenue
|
485.3
|
510.8
|
528.3
|
|||||||||
Non-GAAP Operating Income
|
4.5% op mgn
|
7% op mgn
|
12% op mgn
|
Corporate Performance Measure
|
Weighing
(%)
|
Percentage
Achievement
vs. Target
Performance
(%)
|
Weighted
Payment
Level
(%)
|
|||||||||
Revenue
|
50
|
94
|
0
|
|||||||||
Non-GAAP Operating Income
|
50
|
113
|
109
|
|||||||||
Total
|
54.5
|
Named Executive Officer (1)(2)
|
2022 Base
Salary ($) |
2022 Target
Annual Cash Bonus Opportunity (as a percentage of base salary) |
2022 Target
Annual Cash Bonus
Opportunity
($)(3)
(Pro Rated) |
Company
Multiplier
|
Individual
Multiplier
|
2022 Actual Annual
Bonus Payment ($)(3) |
Approximate 2022
Actual Annual Bonus Payment (as a percentage of the 2022 Target Cash
Annual
Bonus Opportunity)
|
|||||||||||||||||||||
Zander Lurie
|
520,000
|
100
|
%
|
517,027
|
54.5
|
%
|
100.0
|
%
|
281,780
|
54.5
|
%
|
|||||||||||||||||
Priyanka Carr(4)
|
380,000
|
70
|
%
|
260,989
|
54.5
|
%
|
89.0
|
%
|
126,593
|
48.5
|
%
|
|||||||||||||||||
Lora Blum
|
375,000
|
55
|
%
|
205,549
|
54.5
|
%
|
100.0
|
%
|
112,024
|
54.5
|
%
|
|||||||||||||||||
Ken Ewell(5)
|
415,000
|
70
|
%
|
228,130
|
54.5
|
%
|
95.0
|
%
|
118,114
|
51.8
|
%
|
(1) |
Mr. Coulombe and Mr. Schoenstein resigned from their positions prior to the end of the 2022 fiscal year and did not receive a bonus payment pursuant to the terms and conditions of the 2022
Executive Bonus Plan.
|
(2) |
Mr. Sullivan joined the Company in December 2022 and was not eligible to receive a 2022 bonus payment.
|
(3) |
Amounts are calculated using actual earnings in 2022, not annual base salary rates, which were effective in February 2022.
|
(4) |
Ms. Carr’s annual bonus opportunity included a pro-rated target of $17,581 under the Non-Executive Employee Bonus Plan and a pro-rated target of $243,408 under the Executive Bonus Plan. Her
actual bonus payment consisted of $8,528 payable pursuant to her participation in our Non-Executive Employee Bonus Plan prior to her promotion and $118,065 payable pursuant to her participations in our Executive Bonus Plan after she was
appointed our Chief Operating Officer.
|
(5) |
Mr. Ewell’s annual bonus opportunity included a pro-rated target of $108,746 under the Non-Executive Employee Bonus Plan and a pro-rated target of $119,384 under the Executive Bonus Plan.
His actual bonus payment consisted of $56,303 payable pursuant to his participation in our Non-Executive Employee Bonus Plan prior to his promotion and $61,811 payable pursuant to his participation in our Executive Bonus Plan after his
role as Chief Customer Officer was expanded to executive officer status.
|
• |
a competitive market analysis prepared by its compensation consultant;
|
• |
the outstanding equity holdings of each Named Executive Officer (including the current economic value of his or her unvested equity holdings and the ability of these unvested holdings to satisfy our
retention objectives);
|
• |
the projected impact of the proposed awards on our earnings;
|
• |
the proportion of our total shares outstanding used for annual employee long-term incentive compensation awards (our “burn rate”) in relation to the annual burn rate ranges of the companies in our
compensation peer group;
|
• |
the potential voting power dilution to our stockholders in relation to the median practice of the companies in our compensation peer group; and
|
• |
the other factors described in “Compensation-Setting Process — Setting Target Total Direct Compensation” above.
|
• |
Time-based RSAs. The RSAs granted to our CEO vest over a three-year period, with 1/12th of the total number of units subject to an award vesting on May 15, 2022 and 1/12th of the total number of
units subject to the award vesting quarterly thereafter for the remaining 11 quarters, contingent upon the CEO’s continued employment with or service to us through each applicable vesting date.
|
• |
Performance-based RSAs. The number of shares that become eligible to vest under the performance-based RSAs is based on our relative total shareholder return (“TSR”) as compared to the TSR of the
S&P Software & Services Select Industry Index (“SPSISS”) over the scheduled performance period. The SPSISS was selected to align us most closely to our compensation peers. The performance period began on the award’s grant date and
is scheduled to end on the last day of our 2024 fiscal year, with additional performance periods that began on the award’s grant date and ended on the last day of our 2022 fiscal year (the “One-Year Performance Period”) and is scheduled
to end on the last day of our 2023 fiscal year (the “Two-Year Performance Period”). Performance will be measured at the end of each performance period with actual performance compared against pre-established target levels to determine
achievement of the performance goal. The number of shares earned may range from 0% to 200% of the target number of RSAs based on achieved performance during the performance period; provided that up to 33% of the target number of shares
will be eligible to vest on the first and second anniversaries of the award’s grant date, based on performance measured during the One-Year Performance Period and the Two-Year Performance Period, respectively. In the event of a change in
control of the Company, the performance period will be shortened and the number of RSAs that will be eligible to vest (reduced by the number of shares that vested during the One-Year Performance Period and the Two-Year Performance Period,
if any) will be determined based on actual performance, with the Company’s performance measured using the estimated amount to be paid to the Company’s stockholders.
|
• |
Time-based RSAs. The RSAs granted to such NEOs vest over a three-year period, with 1/12th of the total number of units subject to an award vesting on May 15, 2022 and 1/12th of the total number of
units subject to the award vesting quarterly thereafter for the remaining 11 quarters, contingent upon such NEO’s continued employment with or service to us through each applicable vesting date.
|
Named Executive Officer
|
RSA or RSU Awards
(number of shares)
|
PSA Awards
(number of shares)
|
Aggregate
Equity Awards
(grant date fair
value)($)
|
|||||||||
Zander Lurie(1)
|
238,534
|
361,408
|
6,868,121
|
|||||||||
Priyanka Carr
|
199,658
|
–
|
3,274,391
|
|||||||||
Rich Sullivan(2)
|
325,946
|
–
|
2,490,227
|
|||||||||
Ken Ewell(3)
|
200,352
|
–
|
2,621,933
|
|||||||||
Lora Blum
|
119,795
|
–
|
1,964,638
|
|||||||||
Justin Coulombe
|
228,181
|
–
|
3,742,168
|
|||||||||
John Schoenstein
|
142,613
|
–
|
2,338,853
|
(1) |
Mr. Lurie’s PSA award represents the maximum number of shares issued subject to the award. The target number of shares is 180,704. The grant date fair value number reflects the aggregate
grant-date fair value for the target number of shares and is shown in the summary compensation table calculated as described therein. While the target value of Mr. Lurie’s awards was allocated 50% to time-based RSAs and 50% to
performance-based RSAs, a different stock price was used to convert the value into a number of RSAs and performance-based RSAs.
|
(2) |
Equity awards granted to Mr. Sullivan were awarded in connection with his appointment to Chief Financial Officer; excluded is the “Additional Award” he is eligible to receive as outlined in
his employment offer letter.
|
(3) |
Equity awards granted to Mr. Ewell include an award granted in August 2022 in connection with his expanded role responsibilities of the sales-assisted business.
|
Named Executive Officer
|
Stock Options
(number of shares)
|
Aggregate
Equity Awards
(grant date fair
value)($)
|
||||||
Priyanka Carr
|
150,000
|
340,500
|
||||||
Ken Ewell
|
150,000
|
340,500
|
||||||
Lora Blum
|
150,000
|
340,500
|
Name
|
Year
|
Salary ($)
|
Bonus
($)
|
Option
Awards
($)(1)
|
Stock
Awards
($)(1)
|
Non-Equity
Incentive Plan
Compensation
($)
|
All Other
Compensation
($)(2)
|
Total ($)
|
||||||||||||||||||||||
Zander Lurie(3)
|
2022
|
|
517,173
|
—
|
—
|
|
6,868,121
|
|
281,780
|
|
6,865
|
|
7,673,939
|
|||||||||||||||||
Chief Executive Officer
|
2021
|
477,003
|
—
|
5,687,119
|
—
|
453,153
|
6,532
|
6,623,807
|
||||||||||||||||||||||
& Director
|
2020
|
445,000
|
—
|
5,501,673
|
5,605,957
|
396,050
|
5,850
|
11,954,530
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Lora Blum
|
2022
|
373,789
|
—
|
340,500
|
1,964,638
|
112,024
|
6,799
|
2,797,750
|
||||||||||||||||||||||
Chief Legal Officer
|
2021
|
354,455
|
—
|
910,108
|
1,162,051
|
231,504
|
6,532
|
2,664,650
|
||||||||||||||||||||||
& Secretary
|
2020
|
333,750
|
—
|
715,213
|
655,856
|
162,113
|
5,850
|
1,872,782
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Priyanka Carr(4)
|
2022
|
377,173
|
—
|
340,500
|
3,274,391
|
126,593
|
6,685
|
4,125,342
|
||||||||||||||||||||||
Chief Operating Officer
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Ken Ewell(5)
|
2022
|
388,231
|
—
|
340,500
|
2,621,933
|
118,114
|
9,937
|
3,478,715
|
||||||||||||||||||||||
Chief Customer Officer
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Rich Sullivan(6)
|
2022
|
24,808
|
150,000
|
—
|
2,490,227
|
—
|
71
|
2,665,106
|
||||||||||||||||||||||
Chief Financial Officer
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Justin Coulombe(7)
|
2022
|
312,519
|
—
|
—
|
3,742,168
|
—
|
4,337
|
4,059,024
|
||||||||||||||||||||||
Chief Financial Officer
|
2021
|
340,305
|
—
|
1,387,780
|
1,565,870
|
196,643
|
5,155
|
3,495,753
|
||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
John Schoenstein(8)
|
2022
|
328,558
|
205,039
|
—
|
2,338,853
|
—
|
8,598
|
2,881,048
|
||||||||||||||||||||||
Chief Revenue Officer
|
2021
|
420,914
|
—
|
1,137,640
|
1,452,571
|
275,429
|
8,734
|
3,295,288
|
||||||||||||||||||||||
|
2020
|
370,833
|
—
|
1,100,323
|
1,009,005
|
332,497
|
7,907
|
2,820,565
|
(1) |
The amounts reported in the “Option Awards” and “Stock Awards” columns represent the aggregate grant-date fair value of the stock options and/or RSUs, RSAs or PSAs awarded to the Named
Executive Officer in 2022, 2021, and 2020 (if applicable), calculated in accordance with ASC Topic 718. Such grant-date fair value does not consider any estimated forfeitures related to service-vesting conditions. The assumptions used in
determining the grant date fair value of the stock options and/or RSUs, RSAs or PSAs reported in these columns are set forth in the Notes to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the
SEC on February 17, 2023.
|
(2) |
For 2022, the amounts reported include: (i) matching 401(k) contributions of $5,125 for each of Mr. Lurie, Ms. Blum and Ms. Carr, and $6,750 for each of Mr. Ewell and Mr. Schoenstein, and
$3,091 for Mr. Coulombe; (ii) basic group term life insurance on behalf of Mr. Lurie and Ms. Blum ($810 each), Ms. Carr ($486), Mr. Ewell ($2,322), Mr. Sullivan ($48), Mr. Coulombe ($355) and Mr. Schoenstein ($955), and (iii) tax
gross-ups for de minimis perquisites and personal benefits.
|
(3) |
Mr. Lurie serves as our Chief Executive Officer and director, and, from September 30, 2022 through December 12, 2022, following Mr. Coulombe’s resignation as Chief Financial
Officer and before Mr. Sullivan’s appointment as Chief Financial Officer, also served as our interim Chief Financial Officer, but received no additional compensation for the interim role. The Company estimated the grant-date fair value
of Mr. Lurie’s performance stock award (“PSA”) subject to a relative total stockholder return vesting condition using a Monte Carlo
simulation model, with the following assumptions: risk-free interest rate of 2.01%, remaining measurement period of 2.8 years, expected dividend yield of 0.0%, and annualized volatility of 49.8% and 28.3% for our common stock and Index
stock respectively. Based on target achievement level of 100%, the grant date fair value of the award was $18.92 per share. The number of shares to be earned under the PSA may range from 0% to 200% of the target number of shares of
180,704.
|
(4) |
Ms. Carr was promoted to the role of Chief Operating Officer in March 2022, and therefore her compensation set forth in the table above reflects compensation received both prior to her
promotion and as COO. Please also see Compensation Discussion and Analysis – Compensation Setting Process – Compensation Elements – Base Salary above.
|
(5) |
Mr. Ewell’s role as Chief Customer Officer was expanded in August 2022, and therefore his compensation set forth in the table above reflects compensation received both prior to and after the
expansion of his role. Please also see Compensation Discussion and Analysis – Compensation Setting Process – Compensation Elements – Base Salary above.
|
(6) |
Mr. Sullivan was appointed as Chief Financial Officer in December 2022. Accordingly, amounts reported reflect his salary prorated for the portion of 2022 in which he was employed with us.
Mr. Sullivan did not receive an annual cash bonus under the Executive Bonus Plan but instead received a signing bonus of $150,000, payable in two installments of $75,000 each: the first installment was paid in December 2022; and the
second installment was paid in February 2023, at the same time Executive Bonus Plan payments were made to the other NEOs.
|
(7) |
Mr. Coulombe was promoted to the role of Chief Financial Officer in June 2021 and departed in September 2022. Accordingly, amounts reported in 2022 reflect Mr. Coulombe’s salary prorated for
the portion of 2022 in which he was employed with us, and amounts reported in 2021 reflect both compensation received prior to his promotion and during his tenure as Chief Financial Officer. Mr. Coulombe did not receive a 2022 annual cash
bonus.
|
(8) |
Mr. Schoenstein departed as our Chief Revenue Officer in October 2022. Accordingly, amounts reported reflect his salary prorated for the portion of 2022 in which he was employed with us.
While Mr. Schoenstein did not receive a 2022 annual cash bonus under the Executive Bonus Plan, he did receive a mid-year retention bonus of $205,039.
|
|
Estimated future payouts under
non-equity incentive plan
awards(1)
|
Stock
awards
(#)(2)
|
Option
awards
(#)(2)
|
Exercise
price of
option
awards
($/Sh)
|
Grant
date fair
value of
stock
and
option
awards
($)(3)
|
||||||||||||
Name
|
Grant
date
|
Threshold
($)
|
Target
($)
|
Maximum
($)
|
|||||||||||||
Zander Lurie(4)
|
2/25/22
|
260,000
|
520,000
|
780,000
|
—
|
—
|
—
|
—
|
|||||||||
3/13/22 |
—
|
—
|
—
|
599,942
|
—
|
—
|
6,868,121
|
||||||||||
Lora Blum
|
2/25/22
|
103,125
|
206,250
|
309,375
|
119,795
|
—
|
—
|
1,964,638
|
|||||||||
8/29/22 |
—
|
—
|
—
|
—
|
150,000
|
7.14
|
340,500
|
||||||||||
Priyanka Carr
|
2/25/22
|
133,000
|
266,000
|
399,000
|
199,658
|
—
|
—
|
3,274,391
|
|||||||||
8/29/22 |
—
|
—
|
—
|
—
|
150,000
|
7.14
|
340,500
|
||||||||||
Ken Ewell(5)
|
2/25/22
|
—
|
—
|
—
|
128,352
|
—
|
—
|
2,104,973
|
|||||||||
8/24/22 |
145,250
|
290,500
|
435,750
|
72,000
|
—
|
—
|
516,960
|
||||||||||
8/29/22 |
—
|
—
|
—
|
—
|
150,000
|
7.14
|
340,500
|
||||||||||
|
|||||||||||||||||
Rich Sullivan(6)
|
12/13/22
|
150,500
|
301,000
|
451,500
|
325,946
|
—
|
—
|
2,490,227
|
|||||||||
|
|||||||||||||||||
Justin Coulombe(7)
|
2/25/22
|
147,000
|
294,000
|
441,000
|
228,181
|
—
|
—
|
3,742,168
|
|||||||||
|
|||||||||||||||||
John Schoenstein(8)
|
2/25/22
|
170,000
|
340,000
|
510,000
|
142,613
|
—
|
—
|
2,338,853
|
(1) |
All non-equity incentive plan awards were made under the 2022 terms and conditions of our Executive Bonus Plan. Subject to exercise of CEO discretion, an additional individual performance
multiplier ranging from 0% to 130% of a Named Executive Officer’s bonus payment (other than the CEO) may also apply as discussed in Compensation Discussion and Analysis – Compensation-Setting Process – Annual Cash Bonus above.
|
(2) |
Represents number of shares of our common stock underlying each Restricted Stock Award ("RSA"), Performance Restricted Stock Award ("PSA"), Restricted Stock Units award ("RSU") or employee
stock option award under the 2018 Equity Incentive Plan (the “2018 Plan”).
|
(3) |
Amounts reported represent the aggregate grant-date fair value of PSAs, RSAs, RSUs and stock option awards calculated in accordance with ASC Topic 718.
|
(4) |
Mr. Lurie received grants of a PSA and an RSA in March 2022. The PSA award reflects 361,408 shares, which is the maximum number of shares subject to the award. The target number of shares
subject to the award is 180,704. The RSA was granted for 238,534 shares.
|
(5) |
Mr. Ewell received grants of RSUs in February 2022 prior to expansion of his Chief Customer Officer role. In August 2022, following expansion of his Chief Customer Officer role, Mr. Ewell,
received a non-equity incentive grant under the Executive Bonus Plan, an RSU, and an employee stock option.
|
(6) |
Mr. Sullivan joined the Company too late in the year to be eligible for a bonus to be paid under the Executive Bonus Plan. He was paid a signing bonus reflected in the Summary Compensation
Table above.
|
(7) |
Mr. Coulombe departed the Company in September 2022 and, accordingly, was paid no bonus under the Executive Bonus Plan.
|
(8) |
Mr. Schoenstein departed the Company in October 2022 and, accordingly, was paid no bonus under the Executive Bonus Plan. He was paid a mid-year retention bonus reflected in the Summary
Compensation Table above.
|
Option Awards
|
Stock awards
|
|||||||||||||||||||||
Name
|
Grant
Date(1)
|
Number of
securities
underlying
unexercised
options -
exercisable
(#)
|
Number of
securities
underlying
unexercised
options -
unexercisable
(#)
|
Option
exercise
price
($)
|
Option
expiration
date
|
Number of
shares or
units of stock
that have not
vested (#)
|
Market value
of shares or
units of stock
that have not
vested
($)(2)
|
|||||||||||||||
Zander Lurie
|
5/19/2015
|
(3
|
)
|
145,000
|
—
|
16.03
|
5/19/2025
|
|||||||||||||||
8/6/2015
|
(4
|
)
|
190,000
|
—
|
16.03
|
8/6/2025
|
||||||||||||||||
1/16/2016
|
(5
|
)
|
2,200,000
|
—
|
16.03
|
1/16/2026
|
||||||||||||||||
3/5/2018
|
(6
|
)
|
561,000
|
—
|
13.20
|
3/5/2028
|
||||||||||||||||
2/15/2019
|
(7
|
)
|
414,000
|
—
|
12.35
|
2/15/2029
|
||||||||||||||||
2/18/2020
|
(8
|
)
|
387,541
|
176,155
|
21.32
|
2/18/2030
|
||||||||||||||||
2/18/2020
|
(9
|
)
|
88,077
|
616,539
|
||||||||||||||||||
2/16/2021
|
(10
|
)
|
338,865
|
—
|
21.99
|
2/16/2031
|
||||||||||||||||
3/13/2022
|
(11
|
)
|
361,408
|
2,529,856
|
||||||||||||||||||
3/13/2022
|
(12
|
)
|
178,900
|
1,252,300
|
||||||||||||||||||
Lora Blum
|
2/17/2017
|
(13
|
)
|
243,752
|
—
|
16.03
|
2/17/2027
|
|||||||||||||||
3/05/2018
|
(14
|
)
|
7,750
|
—
|
13.20
|
3/5/2028
|
||||||||||||||||
2/15/2019
|
(15
|
)
|
41,668
|
—
|
12.35
|
2/15/2029
|
||||||||||||||||
2/18/2020
|
(16
|
)
|
67,173
|
6,107
|
21.32
|
2/18/2030
|
||||||||||||||||
2/18/2020
|
(17
|
)
|
3,053
|
21,371
|
||||||||||||||||||
2/16/2021
|
(18
|
)
|
50,418
|
36,012
|
21.99
|
2/16/2031
|
||||||||||||||||
2/16/2021
|
(19
|
)
|
18,006
|
126,042
|
||||||||||||||||||
2/25/2022
|
(20
|
)
|
89,846
|
628,922
|
||||||||||||||||||
8/29/2022
|
(21
|
)
|
—
|
150,000
|
7.14
|
8/29/2025
|
||||||||||||||||
Priyanka Carr
|
9/6/2018
|
(22
|
)
|
8,333
|
—
|
13.65
|
9/6/2028
|
|||||||||||||||
2/15/2019
|
(23
|
)
|
8,333
|
—
|
12.35
|
2/15/2029
|
||||||||||||||||
2/18/2020
|
(24
|
)
|
51,671
|
4,697
|
21.32
|
2/18/2030
|
||||||||||||||||
2/18/2020
|
(25
|
)
|
2,349
|
16,443
|
||||||||||||||||||
8/27/2020
|
(26
|
)
|
28,112
|
9,370
|
24.91
|
8/27/2030
|
||||||||||||||||
8/27/2020
|
(27
|
)
|
4,685
|
32,795
|
||||||||||||||||||
2/4/2021
|
(28
|
)
|
13,505
|
94,535
|
||||||||||||||||||
2/16/2021
|
(29
|
)
|
37,813
|
27,010
|
21.99
|
2/16/2031
|
||||||||||||||||
2/25/2022
|
(30
|
)
|
149,743
|
1,048,201
|
||||||||||||||||||
8/29/2022
|
(31
|
)
|
—
|
150,000
|
7.14
|
8/29/2025
|
||||||||||||||||
Ken Ewell
|
2/4/2021
|
(32
|
)
|
31,250
|
218,750
|
|||||||||||||||||
2/16/2021
|
(33
|
)
|
62,500
|
62,500
|
21.99
|
2/16/2031
|
||||||||||||||||
8/25/2021
|
(34
|
)
|
9,850
|
13,790
|
19.67
|
8/25/2031
|
||||||||||||||||
8/25/2021
|
(35
|
)
|
6,895
|
48,265
|
||||||||||||||||||
2/25/2022
|
(36
|
)
|
96,264
|
673,848
|
||||||||||||||||||
8/24/2022
|
(37
|
)
|
66,000
|
462,000
|
||||||||||||||||||
8/29/2022
|
(38
|
)
|
—
|
150,000
|
7.14
|
8/29/2025
|
||||||||||||||||
Rich Sullivan
|
12/13/2022
|
(39
|
)
|
325,946
|
2,281,622
|
|||||||||||||||||
John Schoenstein
|
10/31/2017
|
(40
|
)
|
78,125
|
—
|
16.03
|
10/31/2027
|
|||||||||||||||
3/5/2018
|
(41
|
)
|
29,168
|
—
|
13.20
|
3/5/2028
|
||||||||||||||||
2/15/2019
|
(42
|
)
|
137,500
|
—
|
12.35
|
2/15/2029
|
||||||||||||||||
2/18/2020
|
(43
|
)
|
93,948
|
—
|
21.32
|
2/18/2030
|
||||||||||||||||
2/16/2021
|
(44
|
)
|
54,019
|
—
|
21.99
|
2/16/2031
|
(1) |
Outstanding equity awards granted prior to September 2018 were pursuant to our 2011 Equity Incentive Plan (the “2011 Plan”). All other awards were pursuant to our 2018 Plan. All option
awards under the 2011 Plan may be early exercised.
|
(2) |
The market value of unvested shares is calculated by multiplying the number of unvested shares held by the applicable Named Executive Officer by the closing price of our common stock on
December 31, 2022, which was $7.00.
|
(3) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(4) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(5) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(6) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(7) |
The shares underlying this option were fully vested as of December 31, 2022
|
(8) |
The shares underlying this option vest, subject to Mr. Lurie’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(9) |
The shares underlying this RSU vest, subject to Mr. Lurie’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(10) |
The shares underlying this Performance Option becomes exercisable, subject to Mr. Lurie’s continued role as a service provider to us, if both a Time-Based Service Requirement and a Stock
Price Achievement Requirement are met as follows: (i) the Time-Based Service Requirement vests as to 1/12th of the total shares on May 15, 2021 and quarterly thereafter; and (ii) the Stock Price Achievement Requirement is met if, on or
before February 16, 2025, the average closing price has equaled or exceeded 133% of the Performance Option Exercise Price for 30 consecutive trading days.
|
(11) |
The shares underlying this Performance Restricted Stock Award ("PSA") vest, subject to Mr. Lurie's continued role as a service provider to us, as follows: The number of shares eligible for
vesting under the PSA will depend upon (i) the Issuer's total stockholder return ("TSR") as compared to a specified index (the "Index") over a 3-year performance period ending 12/31/2024 (the "Total Performance Period"); (ii) the Issuer's
TSR as compared to the Index during the 1st year of the Total Performance Period ending 12/31/2022; and (iii) the Issuer's TSR as compared to the Index during the 2nd year of the Total Performance Period ending 12/31/2023. Vesting in each
of the 1st or 2nd years of the Total Performance Period is capped at 1/3 of the target number of shares. On the first anniversary of the award’s grant date, 19,189 shares vested based on performance measured during the One-Year
Performance Period. Shares may also vest in the event of a liquidity event in accordance with the PSA agreement. The maximum number of shares of restricted stock subject to the PSA is 361,408. The target number of shares eligible for
vesting is 180,704, one-half of the maximum number.
|
(12) |
The shares underlying this RSU vest, subject to Mr. Lurie’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2022 and quarterly thereafter.
|
(13) |
The shares underlying this option were fully vested as of December 31, 2022
|
(14) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(15) |
The shares underlying this option were fully vested as of December 31, 2022
|
(16) |
The shares underlying this option vest, subject to Ms. Blum’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(17) |
The shares underlying this RSU vest, subject to Ms. Blum’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(18) |
The shares underlying this option vest, subject to Ms. Blum’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2021 and quarterly thereafter.
|
(19) |
The shares underlying this RSA vest, subject to Ms. Blum’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2021 and quarterly thereafter.
|
(20) |
The shares underlying this RSA vest, subject to Ms. Blum’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2022 and quarterly thereafter.
|
(21) |
All of the shares underlying this option vest, subject to Ms. Blum's continued role as a service provider to us, on August 15, 2023.
|
(22) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(23) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(24) |
The shares underlying this option vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(25) |
The shares underlying this RSU vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter.
|
(26) |
The shares underlying this option vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on November 15, 2020 and quarterly thereafter.
|
(27) |
The shares underlying this RSU vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on November 15, 2020 and quarterly thereafter.
|
(28) |
The shares underlying this RSU vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2021 and quarterly thereafter.
|
(29) |
The shares underlying this option vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2021 and quarterly thereafter..
|
(30) |
The shares underlying this RSA vest, subject to Ms. Carr's continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2022 and quarterly thereafter.
|
(31) |
All of the shares underlying this option vest, subject to Ms. Carr's continued role as a service provider to us, on August 15, 2023.
|
(32) |
The shares underlying this RSU vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/4 of the total shares on November 15, 2021, and then 1/16 of the total shares
vest quarterly thereafter.
|
(33) |
The shares underlying this option vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/4 of the total shares on November 15, 2021, and then 1/16 of the total
shares vest quarterly thereafter.
|
(34) |
The shares underlying this option vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/12th of the total shares on November 15, 2021 and quarterly thereafter.
|
(35) |
The shares underlying this RSU vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/12th of the total shares on November 15, 2021 and quarterly thereafter.
|
(36) |
The shares underlying this RSU vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2022 and quarterly thereafter.
|
(37) |
The shares underlying this RSU vest, subject to Mr. Ewell’s continued role as a service provider to us, as to 1/12th of the total shares on November 15, 2022 and quarterly thereafter.
|
(38) |
All of the shares underlying this option vest, subject to Mr. Ewell's continued role as a service provider to us, on August 15, 2023.
|
(39) |
The shares underlying this RSU vest, subject to Mr. Sullivan's continued role as a service provider to us, as to 1/4 of the total shares on November 15, 2023, and then 1/16 of the total
shares vest quarterly thereafter.
|
(40) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(41) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(42) |
The shares underlying this option were fully vested as of December 31, 2022.
|
(43) |
The shares underlying this option vested, subject to Mr. Schoenstein’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2020 and quarterly thereafter
until Mr. Schoenstein departed as our Chief Revenue Officer in October 2022.
|
(44) |
The shares underlying this option vested, subject to Mr. Schoenstein’s continued role as a service provider to us, as to 1/12th of the total shares on May 15, 2021 and
quarterly thereafter until Mr. Schoenstein departed as our Chief Revenue Officer in October 2022.
|
Option awards
|
Stock awards
|
|||||||||||||||
Name
|
Number of
shares
acquired on
exercise
(#)
|
Value
realized on
exercise
($)(1)
|
Number of
shares
acquired on
vesting
(#)
|
Value
realized on
vesting
($)(2)
|
||||||||||||
Zander Lurie
|
—
|
—
|
147,346
|
1,632,832
|
||||||||||||
Lora Blum
|
—
|
—
|
60,735
|
648,266
|
||||||||||||
Priyanka Carr
|
—
|
—
|
77,401
|
783,308
|
||||||||||||
Ken Ewell
|
—
|
—
|
57,653
|
571,630
|
||||||||||||
Rich Sullivan
|
—
|
—
|
—
|
—
|
||||||||||||
Justin Coulombe
|
—
|
—
|
66,124
|
718,154
|
||||||||||||
John Schoenstein
|
—
|
—
|
57,616
|
672,862
|
(1) |
The value realized upon exercise of option awards is calculated by subtracting the exercise price of the options from the market price of the underlying common stock at the time of exercise.
There were no options exercised by our NEOs in 2022.
|
(2) |
The value realized upon vesting of RSAs and RSUs is calculated by multiplying the number of shares vested by the closing price our common stock on the vest date (or, in the event the vest
date occurs on a holiday or weekend, the closing price on immediately preceding trading day). There were no PSAs that vested in 2022.
|
Name
|
Base Salary
Component
($)
|
Cash Bonus
Component
($)
|
Value of
Accelerated
Equity Awards
($)
|
Value of
Benefits
($)
|
Total
($)
|
|||||||||||||||
Zander Lurie
|
520,000
|
—
|
—
|
53,383
|
573,383
|
|||||||||||||||
Lora Blum
|
187,500
|
—
|
—
|
15,167
|
202,667
|
|||||||||||||||
Priyanka Carr
|
212,500
|
—
|
—
|
6,936
|
219,436
|
|||||||||||||||
Ken Ewell
|
207,500
|
—
|
—
|
15,167
|
222,667
|
|||||||||||||||
Rich Sullivan
|
215,000
|
150,500
|
—
|
11,505
|
377,005
|
Name
|
Base Salary
Component
($)
|
Cash Bonus
Component
($)
|
Value of
Accelerated
Equity Awards
($)
|
Value of
Benefits
($)
|
Total
($)
|
|||||||||||||||
Zander Lurie
|
780,000
|
517,173
|
4,398,695
|
53,383
|
5,749,251
|
|||||||||||||||
Lora Blum
|
375,000
|
205,584
|
776,335
|
15,167
|
1,372,086
|
|||||||||||||||
Priyanka Carr
|
425,000
|
264,021
|
1,191,974
|
6,936
|
1,887,932
|
|||||||||||||||
Ken Ewell
|
415,000
|
271,762
|
1,402,863
|
15,167
|
2,104,792
|
|||||||||||||||
Rich Sullivan
|
430,000
|
15,668
|
2,281,622
|
23,010
|
2,750,300
|
(1) |
Value based on a per share price of $7.00, which was the closing price on December 30, 2022
|
• |
a lump-sum payment equal to (x) 12 months for Mr. Lurie or six months for Mses. Blum and Carr and Messrs. Sullivan, and Ewell of annual base salary as in effect immediately prior to such termination (or if
such termination is due to a resignation for good reason based on a material reduction in base salary, then as in effect immediately prior to the reduction), and (y) with respect to Mr. Sullivan, a portion of his target annual bonus
amount, pro-rated based on number of days of completed service for that fiscal year, provided that if Mr. Sullivan is terminated prior to the six-month anniversary of his start date, the pro-rated bonus amount will be based on six months;
|
• |
payment of premiums for coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), for up to 18 months for Mr. Lurie and up to six months for Mses. Blum and Carr and
Messrs. Sullivan, and Ewell (and for each of their eligible dependents, if any), or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate, or be subject to an excise tax under,
applicable law.
|
• |
a lump-sum payment, less applicable withholdings, equal to the sum of (x) 18 months for Mr. Lurie, and 12 months for Mses. Blum and Carr and Messrs. Sullivan, and Ewell, of annual base salary as in effect
immediately prior to such termination (or if such termination is due to a resignation for good reason based on a material reduction in base salary, then as in effect immediately prior to the reduction or if greater, at the level in effect
immediately prior to the change in control) and (y) a prorated portion of such executive’s target annual bonus as in effect for the fiscal year in which the termination occurs, prorated based on the number of days of completed service for
the fiscal year in which the termination occurs;
|
• |
payment of premiums for coverage under COBRA for the Named Executive Officer and such Named Executive Officer’s eligible dependents, if any, for up to 18 months for Mr. Lurie, for up to 12 months for Mr.
Sullivan, and up to six months for Mses. Blum and Carr and Mr. Ewell, or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate, or be subject to an excise tax under, applicable law;
and
|
• |
(x) with respect to Messrs. Lurie, and Ewell and Mses. Blum and Carr, 100% accelerated vesting and exercisability of all outstanding equity awards and, in the case of an equity award with performance-based
vesting unless otherwise specified in the applicable equity award agreement governing such award, all performance goals and other vesting criteria generally will be deemed achieved at 100% of target levels, and (y) with respect to Mr.
Sullivan, (1) 25% accelerated vesting of all outstanding equity awards (or 50% if the Additional Award is not granted as of the termination date) upon a change in control on or before the 6 month anniversary of his start date, (2) 50%
accelerated vesting of all outstanding equity awards (or 75% if the Additional Award is not granted as of the termination date) upon a change in control between 6 months and one day of his start date and one day prior to the twelve month
anniversary of his start date, and (3) 100% accelerated vesting of all outstanding equity awards upon a change in control after the twelve month anniversary of his start date. The equity award agreement governing Mr. Lurie’s PSA award
provides that in the event of a change in control, the number of shares eligible to vest will be determined based on actual performance. For purposes of this disclosure, we have assumed that the number of shares eligible to vest is
calculated based on achievement at 100% of target levels.
|
• |
the median annual total compensation of all employees of our company, other than our Chief Executive Officer (our “Median Employee”) was $194,970. This annual total compensation was calculated in accordance
with SEC rules, using the same methodology we use for our Named Executive Officers as set forth in our Summary Compensation Table for 2022 (above);
|
• |
the annual total compensation of our Chief Executive Officer, Zander Lurie, as reported for him in our Summary Compensation Table for 2022 (above) was $7,673,939; and
|
• |
the ratio of the annual total compensation of our Chief Executive Officer to the annual total compensation of our Median Employee was approximately 39 to 1.
|
• |
annual base salary rates (annualized where appropriate for partial-year employees);
|
• |
annual variable cash compensation targets (annual bonus or commission); and
|
• |
the fair value on the Determination Date of our guideline equity awards identified for each employee role granted as part of our regular annual equity award grant cycle, calculated using the same
methodology we used for our Named Executive Officers in our Summary Compensation Table for 2022 (above).
|
Annual Cash Compensation for Non-Employee Directors
|
||||||||||||||||
Role |
Board of
Directors
|
Audit
Committee
|
Compensation
Committee
|
Nominating
&
Governance Committee |
||||||||||||
Member
|
$
|
30,000
|
$
|
8,000
|
$
|
5,000
|
$
|
3,500
|
||||||||
Chair
|
$
|
42,000
|
$
|
20,000
|
$
|
10,000
|
$
|
7,500
|
Name
|
Fees Earned
or Paid
in Cash ($)
|
Stock
Awards
($)(1)
|
Option
Awards
($)(1)
|
Total ($)
|
RSUs
Outstanding
(#)(2)
|
Options
Outstanding
(#)(2)
|
||||||||||||||||||
David A. Ebersman
|
45,500
|
120,098
|
—
|
165,598
|
5,025
|
236,176
|
||||||||||||||||||
Lauren Antonoff(3)
|
11,318
|
262,580
|
—
|
273,898
|
36,571
|
—
|
||||||||||||||||||
Susan L. Decker
|
41,005
|
120,098
|
—
|
161,103
|
5,025
|
236,176
|
||||||||||||||||||
Dana L. Evan
|
50,000
|
120,098
|
—
|
170,098
|
5,025
|
236,176
|
||||||||||||||||||
Ryan Finley
|
33,965
|
120,098
|
—
|
154,063
|
5,025
|
26,176
|
||||||||||||||||||
Sagar Gupta(4)
|
25,000
|
360,293
|
—
|
385,293
|
21,775
|
—
|
||||||||||||||||||
Erika H. James
|
37,500
|
120,098
|
—
|
157,598
|
5,025
|
135,551
|
||||||||||||||||||
Sheryl K. Sandberg(5)
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||
Benjamin C. Spero(6)
|
46,334
|
120,098
|
—
|
166,432
|
5,025
|
26,176
|
||||||||||||||||||
Brad D. Smith(7)
|
6,667
|
—
|
—
|
6,667
|
—
|
—
|
||||||||||||||||||
Serena J. Williams(8)
|
17,853
|
120,098
|
—
|
137,951
|
—
|
—
|
(1)
|
The amounts reported in the “Stock Awards” and “Option Awards” columns represent the aggregate grant-date fair value of the RSUs and stock options
awarded to the non-employee director in 2022, calculated in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation—Stock Compensation (“ASC Topic 718”). Such
grant-date fair value does not take into account any estimated forfeitures related to service vesting conditions. The assumptions used in calculating the grant date fair value of the RSUs and stock options reported in these columns
are set forth in the Notes to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on February 17, 2023.
|
(2)
|
As of December 31, 2022, our non-employee directors held outstanding RSUs and outstanding stock options to purchase the number of shares of common
stock set forth in each column.
|
(3)
|
Ms. Antonoff joined our board of directors on August 24, 2022 and her fees are pro-rated accordingly.
|
(4)
|
Mr. Gupta disclaims any compensation for his service as our director and directs it to funds affiliated with Legion Partners.
|
(5)
|
Ms. Sandberg has declined to receive any compensation for her service as a member of our board of directors. She plans to donate the remaining
shares beneficially owned by her (or the proceeds from the sale thereof) to the Sheryl Sandberg and Dave Goldberg Family Foundation as part of fulfilling their philanthropic commitment to the Giving Pledge.
|
(6)
|
Mr. Spero disclaims any compensation for his service as a member of our board of directors and directs it to funds affiliated with Spectrum
Equity.
|
(7)
|
Mr. Smith resigned as a member of our board of directors effective February 28, 2022.
|
(8)
|
Ms. Williams resigned as a member of our board of directors effective August 4, 2022.
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
Plan Category
|
Number of
Securities
to be
Issued upon
Exercise of
Outstanding
Options,
Restricted
Stock Units
and Rights
(#)
|
Weighted
Average
Exercise
Price of
Outstanding
Options
and Rights
($)
|
Number of
Securities
Remaining
Available
for Future
Issuance
Under Equity
Compensation
Plans
(Excluding
Securities
Reflected in
the
first
Column) (#) |
|||||||
Equity compensation plans approved by security holders
|
||||||||||
2011 Equity Incentive Plan(1)
|
7,441,722
|
15.41
|
—
|
|||||||
2018 Equity Incentive Plan(2)
|
13,714,897
|
17.33
|
18,575,514
|
|||||||
2018 Employee Stock Purchase Plan(3)
|
—
|
—
|
5,984,411
|
|||||||
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
|||||||
TOTAL
|
21,156,619
|
16.24
|
24,559,925
|
(1)
|
As a result of the adoption of the 2018 Plan, we no longer grant awards under the 2011 Plan; however, all outstanding options issued pursuant to the 2011 Plan continue
to be governed by their existing terms. To the extent that any such awards are forfeited or lapse unexercised or are repurchased, the shares of common stock subject to such awards will become available for issuance under the 2018
Plan. Includes options to purchase 7,441,722 shares of our common stock and no RSUs outstanding under our 2011 Plan.
|
(2)
|
Our 2018 Plan provides that the number of shares available for issuance under the 2018 Plan will be increased on the first day of each fiscal year, in an amount equal
to the least of (i) 12,500,000 shares, (ii) five percent (5%) of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (iii) such other amount as our board of directors may determine.
Includes options to purchase 5,691,724 shares of our common stock and RSUs representing 8,023,173 shares of our common stock outstanding under our 2018 Plan.
|
(3)
|
Our 2018 Employee Stock Purchase Plan (the “ESPP”) provides that the number of shares available for issuance under the ESPP will be increased on the first day of each
fiscal year, in an amount equal to the least of (i) 5,346,888 shares, (ii) one percent (1%) of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (iii) such other amount as may be
determined by the administrator of the ESPP.
|
• |
each person, or group of affiliated persons, who beneficially owned more than 5% of our common stock;
|
• |
each of our Named Executive Officers;
|
• |
each of our directors and nominees for director; and
|
• |
all of our current executive officers and directors as a group.
|
|
Common Stock
|
|||||||
Name of Beneficial Owner
|
Number
|
Percentage
|
||||||
Named Executive Officers and Directors:
|
||||||||
Zander Lurie(1)
|
5,978,443
|
3.9
|
||||||
Lora D. Blum(2)
|
619,822
|
*
|
||||||
Priyanka Carr(3)
|
424,765
|
*
|
||||||
Ken Ewell(4)
|
219,675
|
*
|
||||||
Rich Sullivan(5)
|
66,068
|
*
|
||||||
Justin Coulombe(6)
|
—
|
*
|
||||||
John S. Schoenstein(7)
|
—
|
*
|
||||||
Lauren Antonoff(8)
|
6,095
|
*
|
||||||
Susan L. Decker(9)
|
294,314
|
*
|
||||||
David A. Ebersman(10)
|
294,314
|
*
|
||||||
Dana L. Evan(11)
|
274,676
|
*
|
||||||
Ryan Finley(12)
|
8,154,603
|
5.4
|
||||||
Sagar Gupta (13)
|
—
|
*
|
||||||
Erika H. James(14)
|
166,812
|
*
|
||||||
Sheryl K. Sandberg(15)
|
8,899,833
|
5.9
|
||||||
Benjamin C. Spero(16)
|
124,122
|
*
|
||||||
All executive officers and directors as a group (17 persons)(17)
|
26,347,230
|
16.7
|
||||||
Greater than 5% Stockholders:
|
||||||||
The Vanguard Group Inc.(18)
|
13,521,099
|
9.0
|
||||||
BlackRock, Inc.(19)
|
10,034,627
|
6.7
|
||||||
ArrowMark Colorado Holdings, LLC(20)
|
9,514,875
|
6.3 | ||||||
Sheryl K. Sandberg Revocable Trust(21)
|
8,899,833
|
5.9
|
||||||
SM Profits, LLC(22)
|
8,105,289
|
5.4
|
||||||
Magnetar Financial LLC(23)
|
7,707,761
|
5.1
|
(1)
|
Mr. Lurie’s ownership includes (i) 39,330 shares held of record by the Jason and Jennifer Lurie Family 2018 Irrevocable Trust dated May 31, 2018, of which Kristin
Vogelsong, Mr. Lurie’s spouse, is the trustee, (ii) 39,330 shares held of record by the Eliza and Larry Becker Family 2018 Irrevocable Trust dated May 31, 2018, of which Ms. Vogelsong is the trustee, (iii) 26,219 shares held of record
by the Scott and Caitlin Vogelsong Family 2018 Irrevocable Trust dated May 31, 2018, of which Ms. Vogelsong is the trustee, (iv) 4,403,686 shares subject to options fully-vested and exercisable within 60 days of the Beneficial
Ownership Date, (v) 88,303 RSUs fully-vested and releasable within 60 days of the Beneficial Ownership Date, (vi) 501,242 shares of common stock underlying RSAs and PSAs.
|
(2)
|
Ms. Blum’s ownership includes (i) 431,273 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, (ii) 21,142 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date, and (iii) 94,268 shares of common stock underlying RSAs.
|
(3)
|
Ms. Carr’s ownership includes (i) 156,010 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, (ii) 37,296 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date, and (iii) 133,105 shares of common stock underlying RSAs.
|
(4)
|
Mr. Ewell’s ownership includes (i) 91,915 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date and (ii) 54,622 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(5)
|
Following Mr. Sullivan’s arrival in December 2022, 66,068 RSUs are fully-vested and releasable within 60 days of the Beneficial Ownership Date. He does not hold any
shares of our common stock.
|
(6)
|
Following Mr. Coulombe’s departure on September 30, 2022, no shares subject to options are fully-vested and exercisable within 60 days of the Beneficial Ownership Date,
and no RSUs are fully-vested and releasable within 60 days of the Beneficial Ownership Date. He does not hold any shares of our common stock.
|
(7)
|
Following Mr. Schoenstein’s departure on October 3, 2022, no shares subject to options are fully-vested and exercisable within 60 days of the Beneficial Ownership Date,
and no RSUs are fully-vested and releasable within 60 days of the Beneficial Ownership Date. He does not hold any registered shares of our common stock.
|
(8)
|
Ms. Antonoff’s ownership includes 3,047 RSUs fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(9)
|
Ms. Decker’s ownership includes (i) 236,176 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (ii) 2,512 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(10)
|
Mr. Ebersman’s ownership includes (i) 236,176 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (ii) 2,512 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(11)
|
Ms. Evan’s ownership includes (i) 236,176 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (ii) 2,512 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(12)
|
Mr. Finley’s ownership includes (i) 8,105,289 shares held of record by SM Profits, LLC, of which Mr. Finley is a manager. Mr. Finley holds a controlling interest with
respect to voting and investment power of the shares held by SM Profits, LLC. See footnote 22 for additional information regarding SM Profits, LLC, (ii) 26,176 shares subject to options fully-vested and exercisable within 60 days of
the Beneficial Ownership Date, and (iii) 2,512 RSUs fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(13)
|
Mr. Gupta does not currently own any equity interests in the Company. Because Mr. Gupta serves on our board of directors as a representative of Legion Partners Asset
Management, LLC and its affiliates, Mr. Gupta does not have a right to any economic interest in our securities granted to him us in respect of his position on our board of directors. Legion Partners Asset Management, LLC is entitled
to receive all of the economic interest in securities granted to Mr. Gupta by us in respect of his position on our board of directors. Mr. Gupta disclaims beneficial ownership of our securities held by Legion Partners Asset
Management, LLC and its affiliates and at no time has he had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management, LLC and its affiliates, entities in which he does
not have a controlling interest and does not have investment control.
|
(14)
|
Ms. James’ ownership includes (i) 135,551 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (ii) 2,512 RSUs
fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(15)
|
Ms. Sandberg’s ownership consists of 8,899,833 shares held of record by the Sheryl K. Sandberg Revocable Trust, of which Ms. Sandberg is a trustee. See footnote 20 for
additional information regarding the Sheryl K. Sandberg Revocable Trust.
|
(16)
|
Mr. Spero’s ownership includes (i) 8,497 shares held of record by Spectrum Equity Management Inc., an affiliate of Spectrum Equity of which Mr. Spero is a managing
director, (ii) 26,176 shares subject to options fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (iii) 2,512 RSUs fully-vested and releasable within 60 days of the Beneficial Ownership Date. Under an
agreement with Spectrum Equity, Mr. Spero is deemed to hold the options and RSUs included herein for the indirect benefit of funds affiliated with Spectrum Equity. Pursuant to the agreement with Spectrum Equity, upon vesting, the
shares underlying the RSUs are issued to and held by Spectrum Equity Management, Inc. Mr. Spero disclaims beneficial ownership of the above shares, options and RSUs and underlying common stock, except to the extent of his pecuniary
interest therein.
|
(17)
|
Consists of 26,347,230 shares beneficially owned by our current executive officers and directors, including (i) 809,314 shares of common stock underlying PSAs and RSAs,
(ii) 6,601,720 shares subject to options held by our current executive officers and directors that are fully-vested and exercisable within 60 days of the Beneficial Ownership Date, and (iii) 304,313 RSUs held by our current executive
officers and directors fully-vested and releasable within 60 days of the Beneficial Ownership Date.
|
(18)
|
According to a Schedule 13G filed with the SEC on February 9, 2023 reporting stock ownership as of December 30,
2022, consists of 13,521,099 shares beneficially owned by The Vanguard Group Inc. and certain of its wholly-owned subsidiaries. The address for the Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.
|
(19)
|
According to a Schedule 13G filed with the SEC on February 1, 2023 reporting stock ownership as of December 31, 2022, consists of 10,034,627 shares beneficially owned
by Blackrock, Inc. or certain of its subsidiaries. The address for BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.
|
(20)
|
According to a Schedule 13G filed with the SEC on April 10, 2023 reporting stock ownership as of March 31, 2023, consists of 9,514,875 shares beneficially owned by
ArrowMark Colorado Holdings, LLC. The address for ArrowMark is 100 Fillmore Street, Suite 325, Denver, Colorado 80206 .
|
(21)
|
Consists of 8,899,833 shares held of record as of April 5, 2023 by the Sheryl K. Sandberg Revocable Trust, of which Ms. Sandberg is a trustee. Ms. Sandberg plans to
donate the remaining shares beneficially owned by her (or the proceeds from the sale thereof) to the Sheryl Sandberg and Dave Goldberg Family Foundation as part of fulfilling their philanthropic commitment to the Giving Pledge.
|
(22)
|
Consists of 8,105,289 shares held of record as of April 5, 2023 by SM Profits, LLC. Ryan Finley is a manager of SM Profits, LLC and holds a controlling interest with
respect to voting and investment power of the shares held by SM Profits, LLC. The address for SM Profits, LLC is 1030 SW Morrison St., Portland, OR 97205.
|
(23)
|
According to a Schedule 13D filed with the SEC on April 6, 2023 reporting stock ownership as of March 28, 2023, consists of 7,707,761 shares beneficially owned by
Magnetar Financial LLC or certain of its affiliates. The address for Magnetar Financial LLC is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201.
|
•
|
the amounts involved exceeded or will exceed $120,000; and
|
•
|
any of our directors, nominees for director, executive officers or beneficial holders of more than 5% of our outstanding capital stock, or any immediate family
member of, or person sharing the household with, any of these individuals or entities (each, a related person), had or will have a direct or indirect material interest.
|
|
Fiscal Year
|
|||||||
|
2022
|
2021
|
||||||
Audit Fees(1)
|
$
|
2,988,500
|
$
|
2,700,000
|
||||
Audit-Related Fees(2)
|
—
|
47,000
|
||||||
Tax Fees(3)
|
431,516
|
702,577
|
||||||
All Other Fees(4)
|
4,125
|
6,875
|
||||||
Total Fees
|
$
|
3,424,141
|
$
|
3,265,442
|
(1)
|
“Audit Fees” consisted of fees for professional services provided in connection with the audit of our consolidated financial statements (including the adoption of new
accounting standards and certain other accounting consultations), quarterly reviews of interim condensed consolidated financial statements and SEC registration statements.
|
(2)
|
“Audit Related Fees” consisted of services provided by the principal accountant that are reasonably related to the performance of the audit or review of our financial
statements not reported as “Audit Fees.”
|
(3)
|
“Tax Fees” related to professional services rendered in connection with tax compliance and preparation relating to tax returns and tax audits, as well as for tax
consulting and planning services.
|
(4)
|
“All Other Fees” consisted of aggregate fees billed for products and services provided by Ernst & Young LLP other than those disclosed above, which is primarily
subscription fees paid for access to online accounting research software.
|
(a) |
The following documents are filed as a part of this Amendment No. 1 on Form 10-K/A:
|
(1) |
Consolidated Financial Statements: Our
consolidated financial statements were previously listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.
|
(2) |
Financial Statement Schedules: Schedules not
listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 or
the notes thereto.
|
(3) |
Exhibits: The documents listed in the following
Exhibit Index of this Amendment No. 1 on Form 10-K/A are incorporated by reference or are filed with this Amendment No. 1 on Form 10-K/A, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).
|
10.17*
|
10-Q
|
001-38664
|
10.1
|
May 5, 2022
|
||||||
10.18*
|
10-Q
|
001-38664
|
10.1
|
August 4, 2022
|
||||||
10.19*
|
10-Q
|
001-38664
|
10.6
|
August 5, 2021
|
||||||
10.20*
|
10-Q
|
001-38664
|
10.1
|
August 7, 2020
|
||||||
10.21
|
10-Q
|
001-38664
|
10.2
|
August 4, 2022
|
||||||
10.22
|
8-K
|
001-38664
|
10.1
|
October 12, 2018
|
||||||
10.23
|
8-K
|
001-38664
|
10.2
|
October 12, 2018
|
||||||
21.1
|
10-K
|
001-38664
|
21.1
|
February 17, 2023
|
||||||
23.1
|
10-K
|
001-38664
|
23.1 |
February 17, 2023
|
||||||
24.1
|
10-K
|
001-38664
|
24.1
|
February 17, 2023
|
||||||
31.1
|
10-K
|
001-38664
|
31.1
|
February 17, 2023
|
||||||
31.2
|
10-K
|
001-38664
|
31.2
|
February 17, 2023
|
||||||
31.3
|
Filed herewith
|
|||||||||
31.4
|
Filed herewith
|
|||||||||
32.1†
|
10-K
|
001-38664
|
32.1
|
February 17, 2023
|
101.INS
|
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL
document.
|
|||||||||
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|||||||||
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|||||||||
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|||||||||
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|||||||||
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|||||||||
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
|
* |
Indicates management contract or compensatory plan.
|
Momentive Global Inc.
|
||
Date: April 14, 2023
|
By:
|
/s/ Richard E. Sullivan Jr. |
Richard E. Sullivan Jr.
|
||
Chief Financial Officer
(Duly Authorized Officer and Principal Financial Officer)
|
Signature
|
Title
|
Date
|
|||
/s/ ALEXANDER J. LURIE |
Chief Executive Officer and Director
|
April 14, 2023
|
|||
ALEXANDER J. LURIE
|
(Principal Executive Officer)
|
||||
/s/ RICHARD E. SULLIVAN, JR. |
Chief Financial Officer
|
April 14, 2023
|
|||
RICHARD E. SULLIVAN, JR.
|
(Principal Financial Officer)
|
||||
/s/ CHERIE BUNTYN |
Chief Accounting Officer and Controller
|
April 14, 2023
|
|||
CHERIE BUNTYN
|
(Principal Accounting Officer)
|
||||
*
|
Chair of the Board of Directors
|
April 14, 2023
|
|||
DAVID A. EBERSMAN
|
|||||
*
|
Director
|
April 14, 2023
|
|||
LAUREN ANTONOFF
|
|||||
*
|
Director
|
April 14, 2023
|
|||
SUSAN L. DECKER
|
|||||
*
|
Director
|
April 14, 2023
|
|||
DANA L. EVAN
|
|||||
*
|
Director
|
April 14, 2023
|
|||
RYAN FINLEY
|
|||||
*
|
Director
|
April 14, 2023
|
|||
SAGAR GUPTA
|
|||||
*
|
Director
|
April 14, 2023
|
|||
ERIKA H. JAMES
|
|||||
*
|
Director
|
April 14, 2023
|
|||
SHERYL K. SANDBERG
|
|||||
*
|
Director
|
April 14, 2023
|
|||
BENJAMIN C. SPERO
|
By:
|
/s/ Richard E. Sullivan Jr. |
Richard E. Sullivan Jr.
|
|
Attorney-in-Fact
|
1. |
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Momentive Global Inc.; and
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: April 14, 2023
|
By:
|
/s/ Alexander J. Lurie
|
Alexander J. Lurie
|
||
Chief Executive Officer and Director
|
||
(Principal Executive Officer)
|
1. |
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Momentive Global Inc.; and
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: April 14, 2023
|
By:
|
/s/ RICHARD E. SULLIVAN JR.
|
Richard E. Sullivan Jr.
|
||
Chief Financial Officer | ||
(Principal Financial Officer)
|